NewEdge Advisors LLC Has $13.04 Million Stock Position in Danaher Co. (NYSE:DHR)

NewEdge Advisors LLC grew its holdings in Danaher Co. (NYSE:DHR) by 7.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,790 shares of the conglomerate’s stock after acquiring an additional 4,129 shares during the quarter. NewEdge Advisors LLC’s holdings in Danaher were worth $13,036,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of DHR. Heck Capital Advisors LLC acquired a new stake in Danaher in the 4th quarter worth $27,000. Decker Retirement Planning Inc. acquired a new position in shares of Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC bought a new position in shares of Danaher during the 4th quarter worth about $31,000. Strategic Financial Concepts LLC acquired a new stake in shares of Danaher during the 4th quarter valued at about $31,000. Finally, Pineridge Advisors LLC increased its stake in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Guggenheim assumed coverage on Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective on the stock. Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. JPMorgan Chase & Co. cut their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Citigroup reaffirmed a “buy” rating on shares of Danaher in a report on Monday, April 7th. Finally, Robert W. Baird set a $231.00 price target on shares of Danaher in a report on Wednesday. Four analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $274.55.

Danaher Stock Down 2.1 %

NYSE DHR opened at $186.71 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The stock has a market capitalization of $133.44 billion, a P/E ratio of 35.36, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. The stock has a fifty day moving average of $202.28 and a 200-day moving average of $227.84.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the company posted $2.09 earnings per share. On average, equities research analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.69%. Danaher’s dividend payout ratio (DPR) is presently 24.24%.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 11.10% of the stock is owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.